Emergent BioSolutions (LTS:0IGA) Float Percentage Of Total Shares Outstanding: 98.44% (As of Jul. 12, 2026)


LTS:0IGA Emergent BioSolutions Inc LTS:0IGA
54 GF Score
Price $7.96
GF Value $4.65
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Emergent BioSolutions Float Percentage Of Total Shares Outstanding?

Emergent BioSolutions LTS:0IGA -1.73% 54 Float Percentage Of Total Shares Outstanding is 98.44% as of Jul. 12, 2026. GuruFocus rates LTS:0IGA with a GF Score™ of 54/100 and a GF Value™ of $4.65 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Emergent BioSolutions's float shares is 50.80 Mil. Emergent BioSolutions's total shares outstanding is 51.60 Mil. Emergent BioSolutions's float percentage of total shares outstanding is 98.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Emergent BioSolutions's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Emergent BioSolutions's Institutional Ownership is 52.77%.

LTS:0IGA
54GF Score
Emergent BioSolutions Inc LTS:0IGA
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emergent BioSolutions Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Emergent BioSolutions's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=50.80/51.60
=98.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 98.44% mean?
Emergent BioSolutions (LTS:0IGA) has a Float Percentage Of Total Shares Outstanding of 98.44% as of Jul. 12, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Emergent BioSolutions and its competitors.
Is Emergent BioSolutions' Float Percentage Of Total Shares Outstanding too high?
Emergent BioSolutions' current Float Percentage Of Total Shares Outstanding is 98.44%. Overall, Emergent BioSolutions has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emergent BioSolutions' Float Percentage Of Total Shares Outstanding compare to ELTP and NIKA?
Emergent BioSolutions' Float Percentage Of Total Shares Outstanding of 98.44% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Emergent BioSolutions and its competitors. Emergent BioSolutions's current Float Percentage Of Total Shares Outstanding is 98.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emergent BioSolutions stock overvalued right now?
Based on GuruFocus' analysis, Emergent BioSolutions (LTS:0IGA) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.65, compared to a current price of $7.96 — trading 71.2% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 98.44%. Emergent BioSolutions' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Emergent BioSolutions (LTS:0IGA), the current Float Percentage Of Total Shares Outstanding is 98.44% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Emergent BioSolutions (LTS:0IGA) Overvalued in 2026?

Based on GuruFocus' analysis, Emergent BioSolutions stock appears to be overvalued. The current stock price of $7.96 is trading 71.2% above its estimated GF Value™ of $4.65. GuruFocus considers Emergent BioSolutions to be Significantly Overvalued.

Key valuation signals for LTS:0IGA:

  • Float Percentage Of Total Shares Outstanding: 98.44%
  • GF Value™: $4.65 vs. price of $7.96 (71.2% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the LTS:0IGA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Emergent BioSolutions Business Description

Other Exchanges EBS:USAER4:Germany
Address 300 Professional Drive, Gaithersburg, MD, USA, 20879
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
54GF Score

Get the complete analysis for LTS:0IGA

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.96
Price
$4.65
GF Value